About 10 years ago, a woman with familial early onset Alzheimer's successfully conceived a healthy baby free of the harmful APP gene mutation through a technique called preimplantation genetic diagnosis (PGD) at a fertility clinic run by the doctor, Yuri Verlinski.
These days another example of selection often crops up: the possibility of couples using PGD to select for an impairment.
Unfortunately it's difficult to prevent these births, even when you know there's a risk, using pre-implantation genetic diagnosis (PGD).
To have genetically-related children, they can either take the risk with natural birth, or have a procedure called preimplantation genetic diagnosis (PGD) which can screen out IVF embryos with highly-mutated DNA.
Reproductive genetic testing is carried out in several ways: through carrier screening, prenatal testing of the fetus in utero, and preimplantation genetic diagnosis (PGD) of embryos created by in vitro fertilization (IVF).
The Preimplantation Genetic Diagnosis International Society was formed in 2002 to provide multidisciplinary research and education in the PGD arena and to advance the science of PGD.
There is also debate about using PGD to eliminate individuals with certain disabilities, such as deafness.
In some countries cases for PGD are first reviewed by experts, who take into consideration the specific genetic disease and the seriousness of the condition and then make recommendations as to whether the procedure should be approved.
While effective for many women, PGD tends to reduce the risk rather than rule it out, and cannot help when all of a woman's embryos have highly-mutated mitochondria.
Another concern is that employing PGD to select for non-disease traits would fail to acknowledge the "giftedness of life" by treating children as "objects of our design or products of our will or instruments of our ambition" rather accepting them as they are given to us (Sandel 2004, 56).
In the U.S., PGD is restricted to private clinics because of the government's ban on the use of federal funds for embryo research.[44] Genetic testing carried out at the population level for any of these purposes is referred to as genetic screening.
